TrialRadiology2017

Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.

Taylor R McClellan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.